Grants and Contributions:
Title:
Sanofi FLUZONE® High-Dose Vaccine Facility and Pandemic Preparedness
Agreement Number:
815915
Agreement Value:
$415,000,000.00
Agreement Date:
Jul 22, 2020 - Jun 30, 2027
Description:
This project will support the development of a new bulk vaccine manufacturing facility and install state of the art drug product formulation, filling, inspection and packaging (FFIP) capabilities in an existing facility in Toronto, Ontario.
Organization:
Innovation, Science and Economic Development Canada
Expected Results:
The investment will allow the company to produce influenza vaccines for global distribution, and will have the potential to ensure a reliable domestic supply. This project anticipates creating 165 full-time jobs and maintaining 1060 full-time jobs.
Location:
Toronto, Ontario, CA M2R3T4
Reference Number:
033-2020-2021-Q4-815915
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
101095263
Recipient Type:
For-profit organization
Additional Information:
This is a non-repayable contribution
Recipient's Operating Name:
Sanofi Pasteur Ltd (withdrawn)
Recipient's Legal Name:
Sanofi Pasteur Ltd
Federal Riding Name:
York Centre
Federal Riding Number:
35118
Program:
SIF Stream3- Attraction
Program Purpose:
-Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services;-Facilitate the growth and expansion of firms in Canada;-Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.
NAICS Code:
325410